Response to: 'Detection of antinuclear antibodies: Added-value of solid phase assay?' by Bossuyt and Fieuws

Annals of the Rheumatic Diseases

Volumn 73, Issue 3, 2014, Pages

  Agmon Levin, Nancy ^a,b   Damoiseaux, Jan ^c   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT ONSET STILL'S DISEASE; AMYLOIDOSIS; ANALGESICS;

ALLERGY AND IMMUNOLOGY; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; HUMANS; RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 84893785369     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204797     Document Type: Letter

References (5)

1. Bossuyt X, Fieuws S. Detection of anti-nuclear antibodies, added-value of solid phase assay? Ann Rheum Dis 2014;73:e10.
2. Agmon-Levin N, Damoiseaux J, Kallenberg C, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2014;73:17-23.
3. Mahler M, Hanly JG, Fritzler MJ. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Autoimmun Rev 2012;11:642-5.
4. Abeles AM, Abeles M. The clinical utility of a positive antinuclear antibody test result. Am J Med 2013;126:342-8.
5. Damoiseaux J, Agmon-Levin N. Anti-Nuclear Antibodies: a long way to harmonization. In: Conrad K, Chen EKL, Fritzler RL, et al. (Eds). Infections, Tumors and Autoimmunity Pabst Science Publishers; Autoantigens, Autoantibodies, Autoimmunity 2013;9:284-289 (E-book).